Lexington Announces First Multicenter Clinical Study Site
August 21, 2018 09:00 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, Aug. 21, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE: LNB) (OTCQB: LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...
Lexington Cardiovascular Health Monitor Performing as Designed with First Clinical Patients
March 05, 2018 03:05 ET
|
Lexington Biosciences, Inc.
VANCOUVER, British Columbia, March 05, 2018 (GLOBE NEWSWIRE) -- Lexington Biosciences, Inc. (CSE:LNB) (OTCQB:LXGTF) (the “Company” or “Lexington”), a development-stage medical device company, is...